{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04789148",
            "orgStudyIdInfo": {
                "id": "2020P003071"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus",
            "officialTitle": "Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot Study",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "effects-of-intranasal-oxytocin-in-patients-with-central-diabetes-insipidus"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-11",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-03-05",
            "studyFirstSubmitQcDate": "2021-03-05",
            "studyFirstPostDateStruct": {
                "date": "2021-03-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-11-30",
            "lastUpdatePostDateStruct": {
                "date": "2022-12-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Elizabeth Austen Lawson",
                "investigatorTitle": "Associate Professor of Medicine, Harvard Medical School; Director, Interdisciplinary Oxytocin Research Program, Neuroendocrine Unit, Massachusetts General Hospital",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Elizabeth Austen Lawson",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, double-blind, placebo-controlled crossover pilot study of single-dose intranasal oxytocin (4 IU and 24 IU) in 18-60-year-old men and women with central diabetes insipidus to evaluate the effect of oxytocin on anxiety, depression and socioemotional functioning.\n\nFollowing a screening visit to determine eligibility, participants will return for three main study visits. During the main study visits, study participants will receive either oxytocin or placebo, followed by assessments of emotional behavior.\n\nThirty participants will be equally randomized to one of six possible drug orders:\n\n1. 4 IU oxytocin - 24 IU oxytocin - placebo\n2. 4 IU oxytocin - placebo - 24 IU oxytocin\n3. 24 IU oxytocin - 4 IU oxytocin - placebo\n4. 24 IU oxytocin - placebo - 4 IU oxytocin\n5. placebo - 4 IU oxytocin - 24 IU oxytocin\n6. placebo - 24 IU oxytocin - 4 IU oxytocin"
        },
        "conditionsModule": {
            "conditions": [
                "Central Diabetes Insipidus"
            ],
            "keywords": [
                "Hypopituitarism",
                "posterior pituitary",
                "oxytocin",
                "psychopathology",
                "anxiety",
                "depressive symptoms",
                "socioemotional functioning"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "4 IU oxytocin - 24 IU oxytocin - placebo",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: 4 IU intranasal oxytocin; Main visit 2: 24 IU intranasal oxytocin; Main visit 3: intranasal placebo",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                },
                {
                    "label": "4 IU oxytocin - placebo - 24 IU oxytocin",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: 4 IU intranasal oxytocin; Main visit 2: intranasal placebo; Main visit 3: 24 IU intranasal oxytocin",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                },
                {
                    "label": "24 IU oxytocin - 4 IU oxytocin - placebo",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: 24 IU intranasal oxytocin; Main visit 2: 4 IU intranasal oxytocin; Main visit 3: intranasal placebo",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                },
                {
                    "label": "24 IU oxytocin - placebo - 4 IU oxytocin",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: 24 IU intranasal oxytocin; Main visit 2: intranasal placebo; Main visit 3: 4 IU intranasal oxytocin",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                },
                {
                    "label": "Placebo - 4 IU oxytocin - 24 IU oxytocin",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: intranasal placebo; Main visit 2: 4 IU intranasal oxytocin; Main visit 3: 24 IU intranasal oxytocin",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                },
                {
                    "label": "Placebo - 24 IU oxytocin - 4 IU oxytocin",
                    "type": "EXPERIMENTAL",
                    "description": "Main visit 1: intranasal placebo; Main visit 2: 24 IU intranasal oxytocin; Main visit 3: 4 IU intranasal oxytocin",
                    "interventionNames": [
                        "Drug: Oxytocin nasal spray"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Oxytocin nasal spray",
                    "description": "4 IU intranasal oxytocin, 24 IU intranasal oxytocin or placebo",
                    "armGroupLabels": [
                        "24 IU oxytocin - 4 IU oxytocin - placebo",
                        "24 IU oxytocin - placebo - 4 IU oxytocin",
                        "4 IU oxytocin - 24 IU oxytocin - placebo",
                        "4 IU oxytocin - placebo - 24 IU oxytocin",
                        "Placebo - 24 IU oxytocin - 4 IU oxytocin",
                        "Placebo - 4 IU oxytocin - 24 IU oxytocin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Dot-probe task - anxious behavior between low dose oxytocin and placebo",
                    "description": "Difference in response times (in milliseconds) to dots appearing in the location of the previously shown negative versus the neutral face between 4 IU oxytocin vs placebo in the dot-probe task.",
                    "timeFrame": "20 minutes following intervention at each main visit"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Dot-probe task - anxious behavior between all three interventions",
                    "description": "Difference in response time (in milliseconds) to dots appearing in the location of the previously shown negative versus neutral face between 4 IU oxytocin, 24 IU oxytocin, and placebo in the dot-probe task.",
                    "timeFrame": "20 minutes following intervention"
                },
                {
                    "measure": "Depressive behavior - probabilistic reward task between all three interventions",
                    "description": "Response bias developed toward the more frequently reinforced alternative between 4 IU oxytocin, 24 IU oxytocin, and placebo in the probabilistic reward task.",
                    "timeFrame": "30 minutes following intervention at each main visit"
                },
                {
                    "measure": "Socioemotional functioning - Emotion recognition task between all three interventions",
                    "description": "Accuracy in identifying correct emotion between 4 IU oxytocin, 24 IU oxytocin, and placebo in the emotion recognition task.",
                    "timeFrame": "40 minutes following intervention at each main visit"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Central diabetes insipidus (based on routine clinical practice, e.g., clinical symptoms, serum and urinary sodium and osmolality levels or the water deprivation test)\n* Normal FT4 or T4\n* Stable hormone replacement (no change in dose of hormone replacement in six weeks prior to baseline)\n\nExclusion Criteria:\n\n* Active substance use disorder within the last 6 months\n* History of psychosis\n* Current suicidal ideation\n* Medication changes within 4 weeks of enrollment or during the study\n* History of cardiac disease, including arrhythmias, coronary heart disease, coronary artery spasms, valvular heart disease, hypertrophic cardiomyopathy (hypertension is not exclusionary)\n* Hyponatremia\n* Creatinine \\>1.5mg/dL.\n* ALT or AST \\>2.5x upper limit of normal\n* Hematocrit less than 2% below the norm\n* Pregnancy or breastfeeding within the last 8 weeks\n* Unwilling to use a medically acceptable form of contraception throughout the study period (female of child-bearing potential only)\n* Received an investigational drug or medical device in the past 30 days or within 5 half-lives of main study visit or be concurrently enrolled in another investigational product clinical trial.\n* Any significant illness or condition that the Investigator determines could interfere with study participation, data collection, or safety",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Elizabeth A Lawson, MD, MMSc",
                    "role": "CONTACT",
                    "phone": "(617) 726-3870",
                    "email": "ealawson@partners.org"
                },
                {
                    "name": "Clara O Sailer, MD, PhD",
                    "role": "CONTACT",
                    "phone": "617-724-2510",
                    "email": "cosailer@mgh.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Elizabeth A Lawson, MD, MMSc",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital, Neuroendocrine Unit",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth A Lawson, MD, MMSc",
                            "role": "CONTACT",
                            "phone": "617-726-3870",
                            "email": "ealawson@partners.org"
                        },
                        {
                            "name": "Clara O Sailer, MD, PhD",
                            "role": "CONTACT",
                            "phone": "617-724-2510",
                            "email": "cosailer@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003919",
                    "term": "Diabetes Insipidus"
                },
                {
                    "id": "D000020790",
                    "term": "Diabetes Insipidus, Neurogenic"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000010900",
                    "term": "Pituitary Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4324",
                    "name": "Anxiety Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M13791",
                    "name": "Pituitary Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7114",
                    "name": "Diabetes Insipidus",
                    "asFound": "Diabetes Insipidus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22545",
                    "name": "Diabetes Insipidus, Neurogenic",
                    "asFound": "Central Diabetes Insipidus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10068",
                    "name": "Hypopituitarism",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1030",
                    "name": "Central Diabetes Insipidus",
                    "asFound": "Central Diabetes Insipidus",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2955",
                    "name": "Hypopituitarism",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010121",
                    "term": "Oxytocin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010120",
                    "term": "Oxytocics"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13041",
                    "name": "Oxytocin",
                    "asFound": "State",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4437",
                    "name": "Arginine Vasopressin",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                }
            ]
        }
    },
    "hasResults": false
}